Feb. 3 at 12:43 PM
$MIST I expected to see this swing traded within the ~
$2 -
$2.50 channel but I guess I was wrong; the lingering warrants overhang makes that tricky.
We have to wait until March to see the Q4 figures, but I would think a lot of the series A
$1.50 warrants have been exercised and flipped in the run up to the fda decision @
$2.50+. That’s what I would have done anyway.
A ticker only for the super patient this; I consider a buyout this year a “certainty”. Easiest plug & play for big pharma.
